Skip to main content

Table 1 Patient characteristics

From: Long-term outcomes of laparoscopic Extralevator Abdominoperineal excision with modified position change for low rectal Cancer treatment

Patient number

Gender

Age (years)

BMI (kg/m2)

ASA class

Distance to anal verge (cm)

Tumor size (cm)

Preoperative stage

nCRT

1

Male

68

22.7

2

3

3

cT2N1M0

No

2

Female

49

21.5

1

3

3.8

cT3N0M0

No

3

Male

63

23.5

1

4

4

cT3N2M0

Yes

4

Male

62

23.1

1

4

4

cT3N2M0

Yes

5

Female

69

25.4

2

3

3

cT3N0M0

No

6

Female

77

25.4

1

3.5

4.8

cT3N0M0

No

7

Male

56

25.4

1

2

4

cT3N0M0

No

8

Male

66

23.4

2

3.5

3.5

cT3N0M0

No

9

Male

59

21.5

2

3

6

cT3N0M0

No

10

Male

57

34.3

2

3

4.5

cT3N2M0

Yes

11

Male

68

19.1

2

3

2

cT2N0M0

No

12

Male

76

22.0

2

2

2.5

cT3N2M0

No

13

Male

68

23.6

2

3

3.5

cT3N2M0

No

14

Female

77

22.2

2

1

5

cT3N2M0

No

15

Female

66

27.6

2

4

5

cT4bN1M0

No

16

Male

58

25.9

1

4

3

cT3N1M0

No

17

Male

56

21.3

1

1

4.5

cT3N2M0

No

18

Female

72

22.1

2

3

5.5

cT3N0M0

No

19

Female

52

23.4

1

3

2.5

cT3N2M0

No

20

Male

66

23.7

1

3

3.5

cT2N1M0

No

21

Female

66

27.1

2

1

1.5

cT2N1M0

No

22

Female

57

21.3

2

3

3.5

cT2N1M0

No

23

Male

54

26.7

1

3

3

cT3N2M0

Yes

24

Male

49

22.6

1

4

6

cT3N0M0

No

25

Male

73

21.2

2

4

5

cT4N2M0

Yes

26

Male

40

23.7

1

5

4.8

cT4N2M0

Yes

27

Male

69

20.3

2

3.5

4.5

cT3N2M0

Yes

28

Female

72

23.2

2

1

7

cT2N0M0

No

29

Male

66

26.3

1

2

8

cT3N2M0

No

30

Male

65

23.0

1

4

4

cT3N0M0

No

31

Female

69

24.0

3

3

4

cT3N0M0

No

32

Female

75

22.4

1

4

6.2

cT4N2M0

Yes

33

Male

78

20.6

2

2

3.7

cT2N2M0

No

34

Female

66

23.2

2

4

3.8

cT3N0M0

No

35

Male

75

23.5

2

1

3

cT3N0M0

No

36

Male

57

20.8

2

5

3.8

cT3N2M0

No

37

Male

63

22.2

1

3

3.6

cT2N0M0

No

38

Male

35

22.5

1

3

5

cT2N0M0

No

39

Female

55

22.5

1

3

3.5

cT3N2M0

Yes

40

Male

47

21.3

1

4

2.5

cT2N0M0

No

41

Female

67

21.4

2

3

2.6

cT3N0M0

No

42

Male

58

27.7

2

4

3.5

cT3N0M0

No

43

Male

62

22.9

1

1

3.5

cT3N0M0

No

44

Male

58

17.3

1

1

7

cT3N0M0

No

45

Male

83

19.6

2

2

2.7

cT2N0M0

No

46

Male

69

25.1

2

2

5.5

cT2N0M0

No

47

Male

66

21.8

2

3

3

cT3N2M0

Yes

48

Male

58

23.0

1

2

2

cT2N2M0

Yes

49

Female

69

26.1

2

2

5

cT2N0M0

No

50

Male

56

26.1

1

3

7.3

cT2N1M0

No

51

Male

67

29.4

1

3

1

cT2N1M0

No

52

Female

60

26.7

2

2

3

cT3N0M0

No

53

Male

59

26.0

1

4

5

cT3N2M0

Yes

54

Male

69

23.9

1

3

3

cT3N1M0

Yes

55

Male

64

23.7

2

3

1.7

cT1N0M0

No

56

Female

71

22.9

1

4

4.5

cT3N0M0

No

  1. ASA American society of anesthesiologists, BMI body mass index, nCRT neoadjuvant chemoradiotherapy